CLINICAL_TRIALS
trial_result
· 2026-06-09
Clinical Trial Update: Study to Assess the Safety and Effectiveness of NMRA-335140-501 [Phase 3]
Summary
Phase 3 clinical trial update for NMRA-335140-501 assessing safety and effectiveness in Major Depressive Disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neumora Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: ACTIVE_NOT_RECRUITING